Brief: Eyegate Pharmaceuticals Files Prospectus Related To Offering Of 3.9 Million Shares Of Common Stock Of Co By Selling Stockholders - SEC Filing
16/04/2021 22:00
April 16 (Reuters) - EyeGate Pharmaceuticals Inc EYEG.O :
* EYEGATE PHARMACEUTICALS FILES PROSPECTUS RELATED TO
OFFERING OF
3.9 MILLION SHARES OF COMMON STOCK OF CO BY SELLING STOCKHOLDERS
- SEC FILING
Source text for Eikon: [https://bit.ly/3drxHHT]
Further company coverage: EYEG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing